Brokerages Anticipate H. Lundbeck A/S- (HLUYY) to Post $0.52 EPS
H. Lundbeck A/S- (NASDAQ:HLUYY) has been given an average broker rating score of 3.00 (Hold) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold rating.
Zacks has also assigned H. Lundbeck A/S- an industry rank of 82 out of 265 based on the ratings given to related companies.
A number of analysts recently issued reports on HLUYY shares. Zacks Investment Research cut H. Lundbeck A/S- from a “buy” rating to a “hold” rating in a research report on Monday, July 17th. Deutsche Bank AG cut H. Lundbeck A/S- from a “hold” rating to a “sell” rating in a research report on Friday, July 28th.
H. Lundbeck A/S- (HLUYY) traded up 3.26% during midday trading on Friday, hitting $66.67. The company had a trading volume of 781 shares. The company has a market cap of $13.15 billion and a price-to-earnings ratio of 42.01. H. Lundbeck A/S- has a 12 month low of $31.00 and a 12 month high of $66.67. The firm has a 50-day moving average price of $61.02 and a 200-day moving average price of $52.67.
About H. Lundbeck A/S-
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for H. Lundbeck A/S- Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S- and related companies with MarketBeat.com's FREE daily email newsletter.